topotecan has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, M; Wang, X; Wang, Y; Yao, L; Zhuang, Y | 1 |
| Albrecht, RA; Aydillo, T; Bakker, J; Balasuriya, UBR; Benner, C; Byun, M; Campisi, L; Carossino, M; Chanda, SK; Chen, H; Escalera, A; Fstkchyan, YS; Garcia-Sastre, A; Gaudreault, NN; Guccione, E; Heinz, S; Ho, JSY; Indran, SV; Jangra, S; Jeyasekharan, AD; Jordan, T; Kaufman, DA; Lau, SY; Lee, AC; Liu, H; Liu, WC; Malysheva, V; Marazzi, I; Meekins, DA; Melo, BS; Miraldi, ER; Mok, BW; Moreira, AL; Morozov, I; Parameswaran, S; Rathnasinghe, R; Ray-Jones, H; Richt, JA; Schotsaert, M; Sebra, R; Shum, E; Spivakov, M; TenOever, BR; Thiecke, MJ; Trujillo, JD; Wayman, JA; Weirauch, MT; White, K; Yildiz, S; Zhang, AJ; Zhao, N; Zheng, S; Zhu, Z | 1 |
1 review(s) available for topotecan and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The recent developments of camptothecin and its derivatives as potential anti-tumor agents.
Topics: Antineoplastic Agents; COVID-19; Drug Liberation; Humans; Irinotecan; Topoisomerase I Inhibitors; Topotecan | 2023 |
1 other study(ies) available for topotecan and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
Topics: Animals; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; DNA Topoisomerases, Type I; Humans; Inflammation; Mesocricetus; Mice; Mice, Transgenic; SARS-CoV-2; THP-1 Cells; Topoisomerase I Inhibitors; Topotecan; Vero Cells | 2021 |